130 related articles for article (PubMed ID: 16636126)
1. Epigenetic modification of the X chromosome influences susceptibility to polycystic ovary syndrome.
Hickey TE; Legro RS; Norman RJ
J Clin Endocrinol Metab; 2006 Jul; 91(7):2789-91. PubMed ID: 16636126
[TBL] [Abstract][Full Text] [Related]
2. Candidate gene region for polycystic ovary syndrome on chromosome 19p13.2.
Urbanek M; Woodroffe A; Ewens KG; Diamanti-Kandarakis E; Legro RS; Strauss JF; Dunaif A; Spielman RS
J Clin Endocrinol Metab; 2005 Dec; 90(12):6623-9. PubMed ID: 16091490
[TBL] [Abstract][Full Text] [Related]
3. Genetics and epigenetics of the X chromosome.
Morey C; Avner P
Ann N Y Acad Sci; 2010 Dec; 1214():E18-33. PubMed ID: 21382199
[TBL] [Abstract][Full Text] [Related]
4. Molecular signatures of X chromosome inactivation and associations with clinical outcomes in epithelial ovarian cancer.
Winham SJ; Larson NB; Armasu SM; Fogarty ZC; Larson MC; McCauley BM; Wang C; Lawrenson K; Gayther S; Cunningham JM; Fridley BL; Goode EL
Hum Mol Genet; 2019 Apr; 28(8):1331-1342. PubMed ID: 30576442
[TBL] [Abstract][Full Text] [Related]
5. Androgen receptor epigenetic variations influence early follicular phase gonadotropin levels.
Laisk T; Haller-Kikkatalo K; Laanpere M; Jakovlev U; Peters M; Karro H; Salumets A
Acta Obstet Gynecol Scand; 2010 Dec; 89(12):1557-63. PubMed ID: 21050150
[TBL] [Abstract][Full Text] [Related]
6. Fine mapping of genetic susceptibility to polycystic ovary syndrome on chromosome 19p13.2 and tests for regulatory activity.
Stewart DR; Dombroski BA; Urbanek M; Ankener W; Ewens KG; Wood JR; Legro RS; Strauss JF; Dunaif A; Spielman RS
J Clin Endocrinol Metab; 2006 Oct; 91(10):4112-7. PubMed ID: 16868051
[TBL] [Abstract][Full Text] [Related]
7. Familial skewed X-chromosome inactivation linked to a component of the cohesin complex, SA2.
Renault NK; Renault MP; Copeland E; Howell RE; Greer WL
J Hum Genet; 2011 May; 56(5):390-7. PubMed ID: 21412246
[TBL] [Abstract][Full Text] [Related]
8. Polycystic ovaries are inherited as an autosomal dominant trait: analysis of 29 polycystic ovary syndrome and 10 control families.
Govind A; Obhrai MS; Clayton RN
J Clin Endocrinol Metab; 1999 Jan; 84(1):38-43. PubMed ID: 9920059
[TBL] [Abstract][Full Text] [Related]
9. Female Hunter syndrome caused by a single mutation and familial XCI skewing: implications for other X-linked disorders.
Kloska A; Jakóbkiewicz-Banecka J; Tylki-Szymańska A; Czartoryska B; Węgrzyn G
Clin Genet; 2011 Nov; 80(5):459-65. PubMed ID: 21062272
[TBL] [Abstract][Full Text] [Related]
10. Heritability of dehydroepiandrosterone sulfate in women with polycystic ovary syndrome and their sisters.
Yildiz BO; Goodarzi MO; Guo X; Rotter JI; Azziz R
Fertil Steril; 2006 Dec; 86(6):1688-93. PubMed ID: 17074350
[TBL] [Abstract][Full Text] [Related]
11. Heritable skewed X-chromosome inactivation leads to haemophilia A expression in heterozygous females.
Renault NK; Dyack S; Dobson MJ; Costa T; Lam WL; Greer WL
Eur J Hum Genet; 2007 Jun; 15(6):628-37. PubMed ID: 17342157
[TBL] [Abstract][Full Text] [Related]
12. Androgen receptor CAG repeat polymorphism and epigenetic influence among the south Indian women with Polycystic Ovary Syndrome.
Dasgupta S; Sirisha PV; Neelaveni K; Anuradha K; Reddy AG; Thangaraj K; Reddy BM
PLoS One; 2010 Aug; 5(8):e12401. PubMed ID: 20865044
[TBL] [Abstract][Full Text] [Related]
13. X chromosome inactivation in Rett Syndrome and its correlations with MECP2 mutations and phenotype.
Xinhua Bao ; Shengling Jiang ; Fuying Song ; Hong Pan ; Meirong Li ; Wu XR
J Child Neurol; 2008 Jan; 23(1):22-5. PubMed ID: 18184939
[TBL] [Abstract][Full Text] [Related]
14. A unified partial likelihood approach for X-chromosome association on time-to-event outcomes.
Xu W; Hao M
Genet Epidemiol; 2018 Feb; 42(1):80-94. PubMed ID: 29178618
[TBL] [Abstract][Full Text] [Related]
15. Evidence from autoimmune thyroiditis of skewed X-chromosome inactivation in female predisposition to autoimmunity.
Ozcelik T; Uz E; Akyerli CB; Bagislar S; Mustafa CA; Gursoy A; Akarsu N; Toruner G; Kamel N; Gullu S
Eur J Hum Genet; 2006 Jun; 14(6):791-7. PubMed ID: 16596118
[TBL] [Abstract][Full Text] [Related]
16. Current concepts in the polycystic ovary syndrome.
Dunaif A; Thomas A
Annu Rev Med; 2001; 52():401-19. PubMed ID: 11160786
[TBL] [Abstract][Full Text] [Related]
17. Skewed X chromosome inactivation in diploid and triploid female human embryonic stem cells.
Liu W; Sun X
Hum Reprod; 2009 Aug; 24(8):1834-43. PubMed ID: 19429659
[TBL] [Abstract][Full Text] [Related]
18. Comment: CAPN10 alleles are associated with polycystic ovary syndrome.
Gonzalez A; Abril E; Roca A; Aragón MJ; Figueroa MJ; Velarde P; Royo JL; Real LM; Ruiz A
J Clin Endocrinol Metab; 2002 Aug; 87(8):3971-6. PubMed ID: 12161543
[TBL] [Abstract][Full Text] [Related]
19. The Role of X-Chromosome Inactivation in Retinal Development and Disease.
Fahim AT; Daiger SP
Adv Exp Med Biol; 2016; 854():325-31. PubMed ID: 26427428
[TBL] [Abstract][Full Text] [Related]
20. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.
Yildiz BO; Yarali H; Oguz H; Bayraktar M
J Clin Endocrinol Metab; 2003 May; 88(5):2031-6. PubMed ID: 12727950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
